Patents by Inventor Nicholas Huby

Nicholas Huby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Wire heated tube with temperature control system, tube type detection, and active over temperature protection for humidifier for respiratory apparatus
    Patent number: 12201768
    Abstract: A PAP system for delivering breathable gas to a patient includes a flow generator to generate a supply of breathable gas to be delivered to the patient; a humidifier including a heating plate to vaporize water and deliver water vapor to humidify the supply of breathable gas; a heated tube configured to heat and deliver the humidified supply of breathable gas to the patient; a power supply configured to supply power to the heating plate and the heated tube; and a controller configured to control the power supply to prevent overheating of the heating plate and the heated tube.
    Type: Grant
    Filed: May 10, 2021
    Date of Patent: January 21, 2025
    Assignee: ResMed Pty Ltd
    Inventors: Andrew Roderick Bath, Donald Angus Richmond, Nathan John Row, Jianhua Zhu, Timothy Nicholas Shadie, Ronald James Huby, Ivan Teodor Dujmovic
  • Substituted hydantoins
    Publication number: 20060063814
    Abstract: The present invention relates to compounds of the formula which are useful in treating diseases characterized by the hyperactivity of MEK. Accordingly the compounds are useful in the treatment of diseases, such as, cancer, cognative and CNS disorders and inflammatory/autoimmune diseases.
    Type: Application
    Filed: September 14, 2005
    Publication date: March 23, 2006
    Inventors: Robert Goodnow,, Nicholas Huby, Norman Kong, Lee McDermott, John Moliterni, Zhuming Zhang
  • Substituted hydantoins
    Publication number: 20060041146
    Abstract: The present invention relates to compounds of the formula which are useful in treating diseases characterized by the hyperactivity of MEK. Accordingly the compounds are useful in the treatment of diseases, such as, cancer, cognative and CNS disorders and inflammatory/autoimmune diseases.
    Type: Application
    Filed: August 11, 2005
    Publication date: February 23, 2006
    Inventors: Xin-Jie Chu, Nader Fotouhi, Nicholas Huby, Norman Kong, Lee McDermott, John Moliterni, Zhuming Zhang